# Complete the medication-safety plan for a hemodialysis client starting etelcalcetide.

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=522761&lang=en  
> language: en  
> subject: Adverse Effects/Contraindications/Interactions  
> category: PPT

## Question

Complete the medication-safety plan for a hemodialysis client starting etelcalcetide.

Stop cinacalcet for at least ::선택::13730 days before starting etelcalcetide. Give etelcalcetide ::선택::beforeduringafterinstead of hemodialysis after blood is no longer circulating through the dialyzer, and check corrected calcium within ::선택::1 week1 month only6 months1 year after initiation or a dose change.

## Explanation

Cinacalcet is discontinued for at least 7 days, etelcalcetide is administered after blood is no longer circulating through the dialyzer, calcium is checked within 1 week of initiation or dose adjustment, and symptomatic or severe hypocalcemia requires stopping and treatment.

## In-depth explanation

Quick answer
Link the switch interval, post-dialysis route, and calcium safety threshold.

Why this is correct
Etelcalcetide is removed by the dialyzer and lowers serum calcium. Overlapping calcium-sensing receptor agonists or giving the dose before dialysis completion increases preventable risk.

Easy analogy or mental picture
Build a medication safety chain: identify the cue cluster, connect it to the drug mechanism, stop preventable exposure, stabilize the client, and verify the response with measurable findings.

Memory hook
Cue cluster, medication mechanism, protective action, and measurable reassessment.

NCLEX decision rule
Choose the action that prevents the most immediate medication-related harm while preserving treatment for the underlying condition.

Why the other choices are wrong
Options that rely on one reassuring value, continue a suspect exposure, bypass monitoring, or delay escalation leave the medication hazard active.References
1DailyMed: PARSABIV (etelcalcetide) prescribing informationPost-dialysis administration, seven-day cinacalcet washout, calcium monitoring, and hypocalcemia management

## Clinical scenario

Medication-safety review
Verify the indication, current assessment, laboratory trend, timing, route, interactions, authorized action, and measurable follow-up.

## Related questions

- [A client is admitted to the emergency department after ingesting an unknown amount of acet…](https://mymerci.kr/pages/nclex_q.php?qn_id=362720&lang=en)
- [A client with chronic heart failure is prescribed metoprolol 25 mg orally twice daily. Bef…](https://mymerci.kr/pages/nclex_q.php?qn_id=362756&lang=en)
- [A 28-year-old client with type 1 diabetes receives regular insulin 6 units and NPH insulin…](https://mymerci.kr/pages/nclex_q.php?qn_id=362792&lang=en)
- [A client receives IV vancomycin 1 g every 12 hours for MRSA bacteremia. Before the next do…](https://mymerci.kr/pages/nclex_q.php?qn_id=362833&lang=en)
- [A client with bipolar disorder has been taking lithium carbonate 600 mg orally three times…](https://mymerci.kr/pages/nclex_q.php?qn_id=362894&lang=en)
- [A nurse is monitoring a client receiving a continuous IV heparin infusion for pulmonary em…](https://mymerci.kr/pages/nclex_q.php?qn_id=363988&lang=en)
- [A nurse is preparing to initiate a weight-based continuous IV unfractionated heparin infus…](https://mymerci.kr/pages/nclex_q.php?qn_id=364107&lang=en)
- [A nurse is providing discharge teaching to a 65-year-old client newly prescribed warfarin …](https://mymerci.kr/pages/nclex_q.php?qn_id=364872&lang=en)

## Read in another language

- [en](https://mymerci.kr/pages/nclex_q.php?qn_id=522761&lang=en)
- [ko](https://mymerci.kr/pages/nclex_q.php?qn_id=522761&lang=ko)
- [ja](https://mymerci.kr/pages/nclex_q.php?qn_id=522761&lang=ja)
- [zh-TW](https://mymerci.kr/pages/nclex_q.php?qn_id=522761&lang=zh-tw)
- [vi](https://mymerci.kr/pages/nclex_q.php?qn_id=522761&lang=vi)

---

More free questions: [NCLEX-RN Practice](https://mymerci.kr/pages/nclex_bank.php?lang=en)

_For study reference only. Always follow current clinical guidelines and your institution’s protocols._